CryoLife, Inc. (NYSE:CRY) Releases Earnings Results, Beats Expectations By $0.02 EPS

CryoLife, Inc. (NYSE:CRY) announced its quarterly earnings data on Monday, July 24th. The medical equipment provider reported $0.12 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.10 by $0.02, Bloomberg Earnings reports. The firm had revenue of $47.80 million during the quarter, compared to analysts’ expectations of $47.02 million. CryoLife had a return on equity of 7.41% and a net margin of 6.16%. The company’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.13 EPS. CryoLife updated its FY17 guidance to $40-0.43 EPS.

Shares of CryoLife (CRY) opened at 19.05 on Friday. CryoLife has a 52 week low of $14.02 and a 52 week high of $20.30. The stock has a market capitalization of $637.15 million, a P/E ratio of 57.73 and a beta of 0.97. The stock has a 50 day moving average price of $19.18 and a 200 day moving average price of $17.98.

In related news, VP Amy Horton sold 9,577 shares of the business’s stock in a transaction that occurred on Tuesday, June 27th. The shares were sold at an average price of $20.00, for a total value of $191,540.00. Following the completion of the transaction, the vice president now directly owns 112,282 shares in the company, valued at approximately $2,245,640. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 6.00% of the stock is currently owned by company insiders.

Large investors have recently made changes to their positions in the stock. Wells Fargo & Company MN raised its stake in shares of CryoLife by 16.5% in the first quarter. Wells Fargo & Company MN now owns 31,042 shares of the medical equipment provider’s stock worth $517,000 after buying an additional 4,399 shares in the last quarter. Essex Investment Management Co. LLC raised its stake in shares of CryoLife by 12.7% in the first quarter. Essex Investment Management Co. LLC now owns 96,643 shares of the medical equipment provider’s stock worth $1,609,000 after buying an additional 10,904 shares in the last quarter. Louisiana State Employees Retirement System raised its stake in shares of CryoLife by 1.9% in the first quarter. Louisiana State Employees Retirement System now owns 11,000 shares of the medical equipment provider’s stock worth $183,000 after buying an additional 200 shares in the last quarter. Macquarie Group Ltd. raised its stake in shares of CryoLife by 2.1% in the fourth quarter. Macquarie Group Ltd. now owns 1,015,375 shares of the medical equipment provider’s stock worth $19,444,000 after buying an additional 20,898 shares in the last quarter. Finally, Teachers Advisors LLC raised its stake in shares of CryoLife by 2.6% in the fourth quarter. Teachers Advisors LLC now owns 51,720 shares of the medical equipment provider’s stock worth $990,000 after buying an additional 1,322 shares in the last quarter. Institutional investors and hedge funds own 69.22% of the company’s stock.

Several brokerages have weighed in on CRY. Zacks Investment Research raised CryoLife from a “sell” rating to a “hold” rating in a report on Monday, August 14th. BidaskClub lowered CryoLife from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. Finally, Northland Securities restated a “buy” rating and set a $23.50 price objective on shares of CryoLife in a research report on Friday, April 28th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. CryoLife has a consensus rating of “Hold” and an average target price of $22.00.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by BNB Daily and is the property of of BNB Daily. If you are reading this piece on another publication, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.baseball-news-blog.com/2017/08/19/cryolife-inc-nysecry-releases-quarterly-earnings-results-beats-expectations-by-0-02-eps-updated-updated-updated.html.

CryoLife Company Profile

CryoLife, Inc (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix.

Earnings History for CryoLife (NYSE:CRY)

Receive News & Ratings for CryoLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply